A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose ofCapecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive,Locally Advanced or Metastatic Breast Cancer Previously Treated

Project: Research project

Project Details

Description

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose of Capecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated
StatusActive
Effective start/end date12/17/1812/31/23

Funding

  • ODONATE THERAPEUTICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.